[ad_1]
NEW HAVEN, Conn., Oct. 20, 2022 /PRNewswire/ — Biohaven Ltd. (NYSE:BHVN) (“Biohaven”) announced today the pricing of the public offering of 25,000,000 of its common shares, at a public offering price of $10.50 per common share. Biohaven has granted the underwriters a 30-day option to purchase up to an additional 3,750,000 common shares. The offering is expected to close on October 25, 2022subject to the satisfaction of customary closing conditions. Biohaven intends to use the net proceeds received from the offering for general corporate purposes.
JP Morgan, Cowen, SVB Securities and Piper Sandler are acting as joint book-running managers of the offering. Cantor and BTIG are acting as co-managers.
The offering will be made only by means of a prospectus. A copy of the prospectus relating to this offering, when available, may be obtained from the following sources: JP Morgan …
Full story available on Benzinga.com
[ad_2]
Source link
